Eubel Brady & Suttman Asset Management’s Amgen AMGN Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	3,709 -1	-0%	-$342	0.16%	53
2026 Q1	$1.3M	Sell	3,710 -583	-14%	-$208K	0.15%	55
2025 Q4	$1.41M	Sell	4,293 -123	-3%	-$39K	0.16%	52
2025 Q3	$1.25M	Buy	+4,416	New	+$1.28M	0.14%	52
2021 Q3	–	Sell	-355	Closed	-$88K	–	83
2021 Q2	$88K	Buy	+355	New	+$87.3K	0.01%	266
2020 Q1	–	Sell	-12,409	Closed	-$98K	–	74
2019 Q4	$98K	Buy	+12,409	New	+$2.74M	0.03%	73

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's AMGN Position: Q2 2026 in Review

Eubel Brady & Suttman Asset Management reduced its Amgen (AMGN) stake by 0.03% in Q2 2026, selling an estimated $342 and leaving 3,709 shares worth $1.34M. The position accounts for 0.16% of the portfolio, ranked #53.

Eubel Brady & Suttman Asset Management first reported a position in AMGN in Q4 2019 and has held it in 6 quarters since. The position peaked at $1.41M in Q4 2025. 3,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Eubel Brady & Suttman Asset Management held 3,709 shares of Amgen worth $1.34M as of Q2 2026.
Eubel Brady & Suttman Asset Management sold 1 Amgen share in Q2 2026, an estimated $342.
Amgen made up 0.16% of Eubel Brady & Suttman Asset Management's portfolio in Q2 2026, its #53 holding.
Eubel Brady & Suttman Asset Management first reported a position in Amgen in Q4 2019 and has held it in 6 quarters since.
Eubel Brady & Suttman Asset Management's Amgen position peaked at $1.41M in Q4 2025.
3,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.